Multiplex assays

• US 20080131875A1
• Filed: 06/07/2006
• Published: 06/05/2008
• Est. Priority Date: 06/07/2006
• Status: Abandoned Application

• Current Assignee: Third Wave Technologies Incorporated (Hologic Incorporated)
• Original Assignee: Third Wave Technologies Incorporated (Hologic Incorporated)
• Inventors: Hall, Jeff G.
• Application Number:
  US11/449,463
• Publication Number:
  US 20080131875A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: C12Q 1/6823 Release of bound markers
• CPC Class Codes: C12Q 2537/143 Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
• CPC Class Codes: C12Q 2561/109 Invader technology
• CPC Class Codes: C12Q 2563/179 the label being a nucleic acid

Abstract

The present invention relates to compositions and methods for the detection and characterization of nucleic acid molecules. More particularly, the present invention relates to methods and compositions employing non cross-hybridizing and minimally cross-hybridizing tags on the 5′ ends of invasive cleavage probes.

Claims

1. A composition comprising a cleavage structure, said cleavage structure comprising:

a) a target nucleic acid having a first region and a second region, wherein said second region is located adjacent to and downstream of said first region;

b) a first nucleic acid molecule comprising a 3′

portion and a 5′

portion, wherein at least a portion of said 3′

portion of said first nucleic acid molecule is completely complementary to said first region of said target nucleic acid, and wherein said 5′

portion contains a tag identifier that is not base-paired to said target nucleic acid and is selected from the group consisting of tag identifiers 1-210 of Table I

wherein;

(A) each of 1 to 22 is a 4mer selected from the group of 4mers consisting of WWWW, WWWX, WWWY, WWXW, WWXX, WWXY, WWYW, WWYX, WWYY, WXWW, WXWX, WXWY, WXXW, WXXX, WXXY, WXYW, WXYX, WXYY, WYWW, WYWX, WYWY, WYXW, WYXX, WYXY, WYYW, WYYX, WYYY, XWWW, XWWX, XWWY, XWXW, XWXX, XWXY, XWYW, XWYX, XWYY, XXWW, XXWX, XXWY, XXXW, XXXX, XXXY, XXYW, XXYX, XXYY, XYWW, XYWX, XYWY, XYXW, XYXX, XYXY, XYYW, XYYX, XYYY, YWWW, YWWX, YWWY, YWXW, YWXX, YWXY, YWYW, YWYX, YWYY, YXWW, YXWX, YXWY, YXXW, YXXX, YXXY, YXYW, YXYX, YXYY, YYWW, YYWX, YYWY, YYXW, YYXX, YYXY, YYYW, YYYX, and YYYY, and

(B) each of 1 to 22 is selected so as to be different from all of the others of 1 to 22;

(C) each of W, X and Y is a base in which;

(i) (a) W=one of A, T/U, G, and C,

X=one of A, T/U, G, and C,

Y=one of A, T/U, G, and C,

and each of W, X and Y is selected so as to be different from all of the others of W, X and Y,

(b) an unselected said base of (i)(a) can be substituted any number of times for any one of W, X and Y, or

(ii) (a) W=G or C,

X=A or T/U,

Y=A or T/U,

and X≠

Y, and

(b) a base not selected in (ii)(a) can be inserted into each sequence at one or more locations, the location of each insertion being the same in all the sequences;

(D) up to three bases can be inserted at any location of any of the sequences or up to three bases can be deleted from any of the sequences;

(E) all of the sequences of a said group of oligonucleotides are read 5′

to 3′

or are read 3′

to 5′

; and

wherein each oligonucleotide of a said set has a sequence of at least ten contiguous bases of the sequence on which it is based, provided that;

(F) (I) the quotient of the sum of G and C divided by the sum of A, TIU, G and C for all combined sequences of the set is between about 0.1 and 0.40 and said quotient for each sequence of the set does not vary from the quotient for the combined sequences by more than 0.2; and

(II) for any phantom sequence generated from any pair of first and second sequences of the set L₁ and L₂ in length, respectively, by selection from the first and second sequences of identical bases in identical sequence with each other;

(i) any consecutive sequence of bases in the phantom sequence which is identical to a consecutive sequence of bases in each of the first and second sequences from which it is generated is less than ((¾

×

L)−

1) bases in length;

(ii) the phantom sequence, if greater than or equal to (⅚

×

L) in length, contains at least three insertions/deletions or mismatches when compared to the first and second sequences from which it is generated; and

(iii) the phantom sequence is not greater than or equal to ( 11/12)×

L) in length;

where L=L₁, or if L₁≠

L₂, where L is the greater of L₁ and L₂; and

wherein any base present may be substituted by an analogue thereof; and

c) a second nucleic acid molecule comprising a 3′

portion and a 5′

portion, wherein said 5′

portion is completely complementary to said second region of said target nucleic acid.

2. The composition of claim 1, further comprising a 5′

nuclease.

3. The composition of claim 2, wherein said 5′

nuclease is a FEN-1 nuclease.

4. The composition of claim 1, wherein said tag identifiers 1-210 are selected from the group consisting of SEQ ID NOS:

1173-1382.

5. A method for detecting the presence of a target nucleic acid molecule in a sample, comprising:

a) incubating a sample with a thermostable 5′

nuclease under conditions wherein a cleavage structure is formed, said cleavage structure comprising;

i) a target nucleic acid having a first region and a second region, wherein said second region is located adjacent to and downstream of said first region;

ii) a first nucleic acid molecule comprising a 3′

portion and a 5′

portion, wherein at least a portion of said 3′

portion of said first nucleic acid molecule is completely complementary to said first region of said target nucleic acid, and wherein said 5′

portion contains a tag identifier that is not base-paired to said target nucleic acid and is selected from the group consisting of tag identifiers 1-210

wherein;

(A) each of 1 to 22 is a 4mer selected from the group of 4mers consisting of WWWW, WWWX, WWWY, WWXW, WWXX, WWXY, WWYW, WWYX, WWYY, WXWW, WXWX, WXWY, WXXW, WXXX, WXXY, WXYW, WXYX, WXYY, WYWW, WYWX, WYWY, WYXW, WYXX, WYXY, WYYW, WYYX, WYYY, XWWW, XWWX, XWWY, XWXW, XWXX, XWXY, XWYW, XWYX, XWYY, XXWW, XXWX, XXWY, XXXW, XXXX, XXXY, XXYW, XXYX, XXYY, XYWW, XYWX, XYWY, XYXW, XYXX, XYXY, XYYW, XYYX, XYYY, YWWW, YWWX, YWWY, YWXW, YWXX, YWXY, YWYW, YWYX, YWYY, YXWW, YXWX, YXWY, YXXW, YXXX, YXXY, YXYW, YXYX, YXYY, YYWW, YYWX, YYWY, YYXW, YYXX, YYXY, YYYW, YYYX, and YYYY, and

(B) each of 1 to 22 is selected so as to be different from all of the others of 1 to 22;

(C) each of W, X and Y is a base in which;

(i) (a) W=one of A, T/U, G, and C,

X=one of A, T/U, G, and C,

Y=one of A, T/U, G, and C,

and each of W, X and Y is selected so as to be different from all of the others of W, X and Y,

(b) an unselected said base of (i)(a) can be substituted any number of times for any one of W, X and Y, or

(ii) (a) W=G or C,

X=A or T/U,

Y=A or T/U,

and X≠

Y, and

(b) a base not selected in (ii)(a) can be inserted into each sequence at one or more locations, the location of each insertion being the same in all the sequences;

(D) up to three bases can be inserted at any location of any of the sequences or up to three bases can be deleted from any of the sequences;

(E) all of the sequences of a said group of oligonucleotides are read 5′

to 3′

or are read 3′

to 5′

; and

wherein each oligonucleotide of a said set has a sequence of at least ten contiguous bases of the sequence on which it is based, provided that;

(F) (I) the quotient of the sum of G and C divided by the sum of A, T/U, G and C for all combined sequences of the set is between about 0.1 and 0.40 and said quotient for each sequence of the set does not vary from the quotient for the combined sequences by more than 0.2; and

(II) for any phantom sequence generated from any pair of first and second sequences of the set L₁ and L₂ in length, respectively, by selection from the first and second sequences of identical bases in identical sequence with each other;

(i) any consecutive sequence of bases in the phantom sequence which is identical to a consecutive sequence of bases in each of the first and second sequences from which it is generated is less than ((¾

×

L)−

1) bases in length;

(ii) the phantom sequence, if greater than or equal to (⅚

×

L) in length, contains at least three insertions/deletions or mismatches when compared to the first and second sequences from which it is generated; and

(iii) the phantom sequence is not greater than or equal to ( 11/12)×

L) in length;

where L=L₁, or if L₁≠

L₂, where L is the greater of L₁ and L₂; and

wherein any base present may be substituted by an analogue thereof; and

iii) a second nucleic acid molecule comprising a 3′

portion and a 5′

portion, wherein said 5′

portion is completely complementary to said second region of said target nucleic acid;

wherein said thermostable 5′

nuclease lacks synthesis activity, and wherein at least a portion of said first nucleic acid molecule is annealed to first region of said target nucleic acid, and wherein at least a portion of said second nucleic acid molecule is annealed to said second region of said target nucleic acid;

b) cleaving said cleavage structure with said thermostable 5′

nuclease so as to generate non-target cleavage product; and

c) detecting the cleavage of said cleavage structure.

6. The method of claim 5, wherein said non-target cleavage product comprises the 5′

portion of said first nucleic acid molecule, and wherein said detecting the cleavage of said cleavage structure comprises detecting annealing of said non-target cleavage product to a third nucleic acid molecule, wherein said third nucleic acid molecule comprises a nucleic acid sequence complementary to the sequence of the tag identifier selected in step (a) (iv).

7. The method of claim 5, wherein said detecting the cleavage of said cleavage structure comprises detection of fluorescence.

8. The method of claim 5, wherein said detecting the cleavage of said cleavage structure comprises detection of fluorescence energy transfer.

9. The method of claim 5, wherein said target nucleic acid comprises DNA.

10. The method of claim 5, wherein said 3′

portion of said second nucleic acid molecule comprises a 3′

terminal nucleotide not complementary to said target nucleic acid.

11. The method of claim 5, wherein said tag identifiers 1-210 are selected from the group consisting of SEQ ID NOS:

1173-1382.

12. A composition comprising a cleavage structure, said cleavage structure comprising:

i) a target nucleic acid having a first region and a second region, wherein said second region is located adjacent to and downstream of said first region;

ii) a first nucleic acid molecule comprising a 3′

portion and a 5′

portion, wherein at least a portion of said 3′

portion of said first nucleic acid molecule is completely complementary to said first region of said target nucleic acid, and wherein said 5′

portion contains a tag identifier that is not base-paired to said target nucleic acid and that is selected from the group consisting of tag identifiers 211-1378, wherein

each of 1 to 3 is a nucleotide base selected to be different from the others of 1 to 3, with the proviso that up to three nucleotide bases of each sequence can be substituted with any nucleotide base provided that for any pair of sequences of the set;

M1≦

16, M2≦

13, M3≦

20, M4≦

16, and M5≦

19, where;

M1 is the maximum number of matches for any alignment in which there are no internal indels;

M2 is the maximum length of a block of matches for any alignment;

M3 is the maximum number of matches for any alignment having a maximum score;

M4 is the maximum sum of the lengths of the longest two blocks of matches for any alignment of maximum score; and

M5 is the maximum sum of the lengths of all the blocks of matches having a length of at least 3, for any alignment of maximum score;

wherein

the score of an alignment is determined according to the equation (A×

m)−

(B×

mm)−

(C×

(o−

g+eg))−

(D×

eg)), wherein;

for each of (i) to (iv);

(i) m=6, mm=6, og=0 and eg=6,

(ii) m=6, mm=6, og=5 and eg=1,

(iii) m=6, mm=2, og=5 and eg=1, and

(iv) m=6, mm=6, og=6 and eg=0,

A is the total number of matched pairs of bases in the alignment;

B is the total number of internal mismatched pairs in the alignment;

C is the total number of internal gaps in the alignment; and

D is the total number of internal indels in the alignment minus the total number of internal gaps in the alignment; and

wherein the maximum score is determined separately for each of (i), (ii), (iii) and (iv); and

iii) a second nucleic acid molecule comprising a 3′

portion and a 5′

portion, wherein said 5′

portion is completely complementary to said second region of said target nucleic acid.

13. The composition of claim 12, further comprising a 5′

nuclease.

14. The composition of claim 13, wherein said 5′

nuclease is a FEN-1 nuclease.

15. The composition of claim 12, wherein said tag identifiers 211-1378 are selected from the group consisting of SEQ ID NOS:

1-1172.

16. A method for detecting the presence of a target nucleic acid molecule in a sample, comprising:

a) incubating a sample with a thermostable 5′

nuclease under conditions wherein a cleavage structure is formed, said cleavage structure comprising;

i) a target nucleic acid having a first region and a second region, wherein said second region is located adjacent to and downstream of said first region;

ii) a first nucleic acid molecule comprising a 3′

portion and a 5′

portion, wherein at least a portion of said 3′

portion of said first nucleic acid molecule is completely complementary to said first region of said target nucleic acid, and wherein said 5′

portion contains a tag identifier that is not base-paired to said target nucleic acid and that is selected from the group consisting of tag identifiers 211-1378, wherein

each of 1 to 3 is a nucleotide base selected to be different from the others of 1 to 3, with the proviso that up to three nucleotide bases of each sequence can be substituted with any nucleotide base provided that for any pair of sequences of the set;

M1≦

16, M2≦

13, M3≦

20, M4≦

16, and M5≦

19, where;

M1 is the maximum number of matches for any alignment in which there are no internal indels;

M2 is the maximum length of a block of matches for any alignment;

M3 is the maximum number of matches for any alignment having a maximum score;

M4 is the maximum sum of the lengths of the longest two blocks of matches for any alignment of maximum score; and

M5 is the maximum sum of the lengths of all the blocks of matches having a length of at least 3, for any alignment of maximum score;

wherein

the score of an alignment is determined according to the equation (A×

m)−

(B×

mm)−

(C×

(o−

g+eg))−

(D×

eg)), wherein;

for each of (i) to (iv);

(i) m=6, mm=6, og=0 and eg=6,

(ii) m=6, mm=6, og=5 and eg=1,

(iii) m=6, mm=2, og=5 and eg=1, and

(iv) m=6, mm=6, og=6 and eg=0,

A is the total number of matched pairs of bases in the alignment;

B is the total number of internal mismatched pairs in the alignment;

C is the total number of internal gaps in the alignment; and

D is the total number of internal indels in the alignment minus the total number of internal gaps in the alignment; and

wherein the maximum score is determined separately for each of (i), (ii), (iii) and (iv); and

iii) a second nucleic acid molecule comprising a 3′

portion and a 5′

portion, wherein said 5′

portion is completely complementary to said second region of said target nucleic acid;

wherein said thermostable 5′

nuclease lacks synthesis activity, and wherein at least a portion of said first nucleic acid molecule is annealed to first region of said target nucleic acid, and wherein at least a portion of said second nucleic acid molecule is annealed to said second region of said target nucleic acid;

b) cleaving said cleavage structure with said thermostable 5′

nuclease so as to generate non-target cleavage product; and

c) detecting the cleavage of said cleavage structure.

17. The method of claim 16, wherein said non-target cleavage product comprises the 5′

portion of said first nucleic acid molecule, and wherein said detecting the cleavage of said cleavage structure comprises detecting annealing of said non-target cleavage product to a third nucleic acid molecule, wherein said third nucleic acid molecule comprises a nucleic acid sequence complementary to the sequence of the tag identifier selected in step (a) (iv).

18. The method of claim 16, wherein said detecting the cleavage of said cleavage structure comprises detection of fluorescence.

19. The method of claim 16, wherein said detecting the cleavage of said cleavage structure comprises detection of fluorescence energy transfer.

20. The method of claim 16, wherein said target nucleic acid comprises DNA.

21. The method of claim 16, wherein said 3′

portion of said second nucleic acid molecule comprises a 3′

terminal nucleotide not complementary to said target nucleic acid.

22. The method of claim 16, wherein said tag identifiers 211-1378 are selected from the group consisting of SEQ ID NOS:

1-1172.